Manuel S. Eisenberg
- Sep 29, 2020
- 1 min read

UroLift updates in the BPH guidelines

UroLift (prostatic urethral lift) is a featured management in the treatment of enlarged prostate/BPH. Recent American Urologic Association guidelines were amended highlighting the appropriateness and benefits of UroLift in patients with urinary symptoms from an enlarged prostate. The updated guidelines support the use of this procedure especially for glands <80g, emphasized the beneficial outcomes in recent studies, and reaffirmed preservation of erectile and ejaculatory function. UroLift is definitely within the standard of care, and possible the go-to treatment, in the majority of men with bothersome urinary symptoms.

Recent Posts

See All

UroLift continues to do well in "real world" studies

Results of UroLift were evaluated in a group of 2000 patients. Of these patients, 153 required some type of intervention during follow up. The overall reintervention rate was calculated at 6% per ye

Sexual function is a significant consideration when undergoing treatment for BPH

The majority of men over 50 years old have some degree of urinary symptoms due to an enlarge prostate. Both medications and surgery for the treatment of these symptoms can have side effects, includin

UroLift performs better than Rezume in the “real world”

A recent study compared the early outcomes of UroLift (prostatic urethral lift) versus Rezume (prostate steam therapy) in patients in the community/”real work” setting. The early outcomes show superi